ArmorMax and LVR, leading providers of refractory solutions, are proud to announce the opening of their new facility in Columbia, South Carolina. This strategic expansion aims to better serve the ...

The following press release was distributed by the American Society for Radiation Oncology (ASTRO)Phase 2 clinical trial ...

Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced the completion of the acquisition of ...

In the largest prospective study to date examining the use of chimeric antigen receptor (CAR)-T therapy in a community ...

In the largest prospective study to date examining the use of chimeric antigen receptor (CAR)-T therapy in a community ...

A radiopharmaceutical therapy that has successfully extended progression-free survival for patients with neuroendocrine tumors shows early promise for delivering similar benefits to patients with ...

The conversion price of the convertible notes will be US$9.06 per ADR (American Depository Receipt) equivalent to A$1.32 per ASX-listed share, representing a 25% premium to Mesoblast’s 5-day volume ...

In a study recently published in Engineering, scientists from the University of Science and Technology Beijing, Guangdong ...

Freemelt has received an order for a Freemelt ONE PBF-EB Additive Manufacturing machine from a leading research institute.

During the 131st SLSWCA meeting held under chairmanship of Chief Secretary Manoj Ahuja, the investment plans across various ...

Nevro noted that it expects to launch its full market release of HFX iQ with HFX AdaptivAI in the U.S. in the fourth quarter of 2024. For more information on HFX AdaptivAI, please visit ...